CANNOVATION
Live / Allowed — Published for opposition (as of 17 Mar 2026)
What this means for you
Approved and waiting on proof of use. It will register unless the applicant drops it, and its 29 Feb 2024 filing date already counts against anyone who files later.
Record
- Serial number
- 98428094
- Mark type
- Stylized text
- Filed
- 29 Feb 2024
- Published for opposition
- 17 Mar 2026
- Attorney of record
- John S. Kendall
Goods and services
- Class 035 — Advertising and business services: Business consulting and process assessment services in the nature of Business planning, Clinical trial design and administration, DEA and FDA Regulatory Consulting, Supply development, project management, commercialization strategies in the field of prescription and non-prescription drugs and products; business consulting relating to regulatory compliance, namely providing guidance and recommending resources to assist with regulatory and legal issues; consulting services to assist drug and non-drug companies in the field of business and program management; business planning; Business planning in the field of distribution and product distribution management; business consulting services in the field of government and regulatory compliance; business services in the field of regulatory compliance strategy, namely develop and provide regulatory strategy; business advisory services in the fields of goods or services sourcing, supply chain management; business services namely, providing guidance in the field of importation and exportation product sourcing and logistics; business advisory services, namely consulting services in the field of coordinating the supply chains of national and internation FDA registered drug, API and excipient manufacturers in the fields of international and domestic market entry; and business consulting, management and planning in the field of Medical device, pharmaceutical and nutraceutical product development and clinical research; none of the foregoing providing cannabis or hemp
- Class 042 — Scientific and technological services: Clinical research consulting, analysis and study services in the field of drug evaluation; clinical research consulting services in the field of pharmaceuticals; and clinical research consulting and advisory services related to ensuring the safety of pharmaceutical preparations; none of the foregoing providing cannabis or hemp
- Class 045 — Legal and security services: Product licensing; and product licensing consultancy relating to licensing pharmaceuticals and non-drug products.
Owner
- CCR Partners, LLC, Buford, GA, US
- CCR Partners, LLC, Buford, GA, US
Prosecution history
- 17 Mar 2026 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 17 Mar 2026 — PUBLISHED FOR OPPOSITION
- 11 Mar 2026 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 20 Feb 2026 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 04 Feb 2026 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 04 Feb 2026 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 04 Feb 2026 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
- 20 Jan 2026 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 20 Jan 2026 — NON-FINAL ACTION E-MAILED
- 20 Jan 2026 — NON-FINAL ACTION WRITTEN
- 22 Dec 2025 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 22 Dec 2025 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 22 Dec 2025 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
- 21 Nov 2025 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 21 Nov 2025 — NON-FINAL ACTION E-MAILED